We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Genes2Me

Genes2Me is a leading IVD solutions manufacturer which offers NGS clinical panels, molecular POC testing solutions, R... read more Featured Products: More products

Download Mobile App




Fully Automated Detection System Revolutionizes Point-Of-Care Testing

By LabMedica International staff writers
Posted on 16 Jun 2025

A state-of-the-art, fully automated system simplifies diagnostics by integrating nucleic acid extraction and real-time PCR (RT-PCR) detection into a single, streamlined process. More...

Its user-friendly design, rapid turnaround time, and high sensitivity make it an essential tool for faster, more accurate point-of-care (POC) testing.

The OnePCR fully automated detection system from Genes2Me (Haryana, India) promises to transform POC testing. With its innovative design, OnePCR offers a simplified sample-to-result process that eliminates the need for transferring samples between devices. Utilizing advanced cartridge technology, it combines nucleic acid extraction and RT-PCR into a single integrated instrument, reducing the risk of human error. This simple “Sample In—result out” device streamlines workflow, delivering fast and accurate diagnostics in under 90 minutes. Its Multi-Target Detection capability can identify up to 20 targets from a single sample, making it a highly versatile tool for comprehensive diagnostics. Equipped with a five-channel fluorescence system and an innovative circular cassette design, it ensures precise nucleic acid extraction and RT-PCR-based fluorescence detection.

OnePCR operates independently with robotic liquid handling, completing each run in 30-70 minutes, providing rapid and reliable results. The system uses a single-use, disposable, sealed extraction and PCR cartridge to prevent contact with the instrument, environment, or carryover contamination. Built-in HEPA filters and UV light sterilization ensure efficient, contamination-free results. Its compact, lightweight, and ergonomic design is complemented by built-in, intuitive automated reporting software for seamless operation. OnePCR is equipped with QR code scanning on the cartridge for quick access to experiment protocols and features a user-friendly, intuitive built-in software to enhance efficiency and convenience.

Designed to be used beyond traditional lab environments, it can be operated by semi-skilled personnel with ease. The system includes pre-filled cartridges for both extraction and amplification, eliminating the need for manual liquid transfers and streamlining the process even further. OnePCR utilizes magnetic bead-based extraction technology, ensuring efficient and reliable nucleic acid extraction. Additionally, it can connect to multiple independent modules, allowing for multi-sample analysis, further enhancing its capacity and flexibility for high-throughput testing. The OnePCR system has now received 510(k) clearance from the U.S. Food and Drug Administration (FDA), paving the way for the company to market and deploy its integrated qPCR platform across clinical laboratories, hospitals, and POC settings in the United States.

Related Links:
Genes2Me


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Automated Immunoassay Analyzer
SuperFlex™
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Acute lymphoblastic leukemia in children and young people requires careful relapse risk assessment as treatment expands beyond standard chemotherapy. (Image Credit: Shutterstock)

New Risk-Stratification Tool Predicts Relapse After Blinatumomab in Childhood ALL

Acute lymphoblastic leukemia in children and young people requires careful assessment of relapse risk, particularly as treatment approaches move beyond standard chemotherapy. Traditional relapse predictors... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Decentralized Laboratory Network Improves Detection of Viral Hemorrhagic Fevers in Guinea

Viral hemorrhagic fevers remain a major diagnostic challenge in West Africa because their early symptoms can resemble those of other febrile illnesses. The 2014–2016 Ebola epidemic underscored the need... Read more

Pathology

view channel
Image Credit: Adobe Stock

AI Pathology Approach Closely Aligns With Breast Cancer Genomic Risk Classification

In early-stage breast cancer, precision oncology relies on biological information to guide personalized treatment decisions. Because access to tissue-based genomic testing may be limited, there is growing... Read more

Technology

view channel
Image Credit: Adobe Stock

AI Models Use Routine Blood Tests and Health Records to Predict Cancer Risk

Cancer screening programs cover only certain cancers and often rely on broad eligibility criteria, limiting individualized risk assessment across multiple cancer types. Routine health data, including blood... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.